Literature DB >> 32730095

COVID-19: a wreak havoc across the globe.

Heena Rehman1, Md Iftekhar Ahmad2.   

Abstract

Coronavirus disease (COVID-19) is an infectious airborne viral pneumonia caused by a novel virus belonging to the family coronaviridae. On February 11, 2019, the Internal Committee on Taxonomy of Virus (ICTV) announced the name of the novel virus as "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). One of the proteins present on its membrane i.e. the Spike protein is responsible for the attachment of the virus to the host. It spreads through the salivary droplets released when an infected person sneezes or coughs. The best way to slow down the disease is by protecting self by washing hands and using the disinfectant. Most of the infected people experience mild to moderate breathing issues. Serious illness might develop in people with underlying cardiovascular problems, diabetes and other immuno-compromised diseases. To date, there is no effective medicine available in the market which is effective in COVID-19. However, healthcare professionals are using ritonavir, flavipiravir, lopinavir, hydroxychloroquine and remdesivir. Along with the medicines, some countries are using convalescent plasma and mesenchymal stem cells for treatment. Till date, it has claimed millions of death worldwide. In this detailed review, we have discussed the structure of SARS-CoV-2, essential proteins, its lifecycle, transmission, symptoms, pathology, clinical features, diagnosis, prevention, treatment and epidemiology of the disease.

Entities:  

Keywords:  ACE2; COVID-19; acute respiratory distress syndrome; cellular and humoral immunity; polymerase chain reaction; real time reverse transciptase; spike protein

Year:  2020        PMID: 32730095     DOI: 10.1080/13813455.2020.1797105

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   4.076


  2 in total

1.  A Comparative Study of Nine SARS-CoV-2 IgG Lateral Flow Assays Using Both Post-Infection and Post-Vaccination Samples.

Authors:  Leontine Mulder; Benoit Carrères; Franco Muggli; Alix Zollinger; John Corthésy; Adrianne Klijn; Giuseppe Togni
Journal:  J Clin Med       Date:  2022-04-08       Impact factor: 4.964

2.  Lung Opacity and Coronary Artery Calcium Score: A Combined Tool for Risk Stratification and Outcome Prediction in COVID-19 Patients.

Authors:  Vitali Koch; Leon D Gruenewald; Moritz H Albrecht; Katrin Eichler; Tatjana Gruber-Rouh; Ibrahim Yel; Leona S Alizadeh; Scherwin Mahmoudi; Jan-Erik Scholtz; Simon S Martin; Lukas Lenga; Thomas J Vogl; Nour-Eldin A Nour-Eldin; Florian Bienenfeld; Renate M Hammerstingl; Christiana Graf; Christof M Sommer; Stefan E Hardt; Silvio Mazziotti; Giorgio Ascenti; Giovanni Antonio Versace; Tommaso D'Angelo; Christian Booz
Journal:  Acad Radiol       Date:  2022-02-28       Impact factor: 5.482

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.